Contraceptive methods and fertility testing in young adult survivors of childhood cancer
Brooke Cherven(Emory University), Vicky Lehmann(Amsterdam University Medical Centers), Gabriele Calaminus(University Hospital Bonn), Lauren F. Quast(Emory University), Peter Kaatsch(Johannes Gutenberg University Mainz), Mariët Hagedoorn(University Medical Center Groningen), Cynthia A. Gerhardt(Nationwide Children's Hospital), Katja Baust(University Hospital Bonn), James L. Klosky(Emory University), Marrit A. Tuinman(University Medical Center Groningen)
Cited by 4
Related Papers
International Classification of Childhood Cancer, third edition
|Cancer|2005|1.5k
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419